Literature DB >> 971963

In vivo and in vitro studies on possible pathogenic mechanisms of Actinomyces viscosus.

D Engel, D V Epps, J Clagett.   

Abstract

Actinomycotic infections are characterized by long-term inflammatory lesions containing large numbers of polymorphonuclear leukocytes (PMNs) and mononuclear cells. The pathogenic mechanisms involved in these lesions are not understood. Homogenates of Actinomyces viscosus (AVIS) induce an acute inflammatory response with a predominance of PMNs within 6 h after injection into the footpads of nonimmunized mice. These homogenates, when tested in vitro, contain potent chemotactic activity for human PMNs. In vitro chemotactic activity for human monocytes is weak but statistically significant (P less than 0.025). Doses of AVIS, which alone have little chemotactic activity, cause the generation of PMN chemotactic activity in fresh, but not complement-inactivated, serum. The injection of AVIS into the footpads of immunized mice induces an acute inflammatory response followed within 48 h by a mononuclear cell infiltrate, suggesting that factors affecting monocyte accumulation are generated by the immune host in response to challenge with the bacterial antigens. These findings indicate that the pathogenicity of the Actinomyces may result in part from (i) their direct chemotactic effect on PMNs, (ii) their cytotaxigenic effects on serum, and (iii) their ability to stimulate host immune cells to produce and release mediators of inflammation.

Entities:  

Mesh:

Year:  1976        PMID: 971963      PMCID: PMC420917          DOI: 10.1128/iai.14.2.548-554.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Lymphokine-induced production and release of lysosomal enzymes by macrophages.

Authors:  R M Pantalone; R C Page
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

Review 2.  Leukotaxis and leukotactic disorders. A review.

Authors:  P A Ward
Journal:  Am J Pathol       Date:  1974-12       Impact factor: 4.307

Review 3.  Participation of mononuclear phagocytes in chronic inflammatory diseases.

Authors:  R C Page; P Davies; A C Allison
Journal:  J Reticuloendothel Soc       Date:  1974-05

Review 4.  Leukocytic proteases and the immunologic release of lysosomal enzymes.

Authors:  G Weissmann; R B Zurier; S Hoffstein
Journal:  Am J Pathol       Date:  1972-09       Impact factor: 4.307

5.  Periodontal lesions in hamsters and gnotobiotic rats infected with actinomyces of human origin.

Authors:  H V Jordan; P H Keyes; S Bellack
Journal:  J Periodontal Res       Date:  1972       Impact factor: 4.419

6.  Histological changes in experimental periodontal disease in gnotobiotic rats and conventional hamsters.

Authors:  J T Irving; S S Socransky; J D Heeley
Journal:  J Periodontal Res       Date:  1974       Impact factor: 4.419

7.  Cellular immunity in the mouse. II. Correlation of in vivo and in vitro phenomena.

Authors:  S M Phillips; C B Carpenter; J P Merrill
Journal:  Cell Immunol       Date:  1972-10       Impact factor: 4.868

8.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

9.  Streptolysin O inhibition of neutrophil chemotaxis and mobility: nonimmune phenomenon with species specificity.

Authors:  D E Van Epps; B R Andersen
Journal:  Infect Immun       Date:  1974-01       Impact factor: 3.441

10.  The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes.

Authors:  S BOYDEN
Journal:  J Exp Med       Date:  1962-03-01       Impact factor: 14.307

View more
  9 in total

1.  Degradation of levan by Actinomyces viscosus.

Authors:  C H Miller; P J Somers
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

2.  Effects of endogenous and exogenous inhibitors on the incorporation of labeled precursors into DNA by human mononuclear cells.

Authors:  T J Sims; R C Page
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

3.  Morphological features and functional properties of human fibroblasts exposed to Actinomyces viscosus substances.

Authors:  D Engel; H E Schroeder; R C Page
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

4.  In vitro stimulation of immunoglobulin production from human peripheral blood lymphocytes by a soluble preparation of Actinomyces viscosus.

Authors:  D F Mangan; D E Lopatin
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

5.  Comparative histopathology of lesions produced by Actinomyces israelii, Actinomyces naeslundii, and Actinomyces viscosus in mice.

Authors:  M J Behbehani; J D Heeley; H V Jordan
Journal:  Am J Pathol       Date:  1983-03       Impact factor: 4.307

6.  Cell-associated levan of Actinomyces viscosus.

Authors:  T N Warner; C H Miller
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

7.  Interaction of inflammatory cells and oral microorganisms. VII. In vitro polymorphonuclear responses to viable bacteria and to subcellular components of avirulent and virulent strains of Actinomyces viscosus.

Authors:  N S Taichman; B F Hammond; C C Tsai; P C Baehni; W P McArthur
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

8.  SARS-CoV-2-Indigenous Microbiota Nexus: Does Gut Microbiota Contribute to Inflammation and Disease Severity in COVID-19?

Authors:  Indranil Chattopadhyay; Esaki M Shankar
Journal:  Front Cell Infect Microbiol       Date:  2021-03-11       Impact factor: 6.073

Review 9.  Actinomyces and Alimentary Tract Diseases: A Review of Its Biological Functions and Pathology.

Authors:  Jun Li; Ying Li; Yu Zhou; Changzheng Wang; Benyan Wu; Jun Wan
Journal:  Biomed Res Int       Date:  2018-08-26       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.